Medi Assist Healthcare Intrinsic Value
Medi Assist Healthcare intrinsic value. Medi Assist Healthcare (MEDIASSIST) median intrinsic value is ₹244.31 from 10 valuation models (range ₹84–₹433), vs current price ₹279.80 — -12.7% downside (Trading Above Median Value), margin of safety -14.5%. Analyse MEDIASSIST shareholding pattern to track promoter, FII and institutional holdings.
MEDIASSIST Valuation Methods Summary — DCF, Graham Number & P/E
Medi Assist Healthcare intrinsic value across 10 models vs current price ₹279.80 — upside/downside and value range per method. Browse MEDIASSIST annual financials for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹138.24 | ₹110.59 - ₹165.89 | -50.6% | EPS: ₹11.52, Sector P/E: 12x |
| Book Value Method | asset | ₹184.22 | ₹165.80 - ₹202.64 | -34.2% | Book Value/Share: ₹230.27, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹264.86 | ₹238.37 - ₹291.35 | -5.3% | Revenue/Share: ₹264.86, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹286.49 | ₹257.84 - ₹315.14 | +2.4% | EBITDA: ₹212.00Cr, EV/EBITDA: 5x |
| Simple DCF (5Y) | dcf | ₹433.20 | ₹346.56 - ₹519.84 | +54.8% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹83.94 | ₹75.55 - ₹92.33 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹94.92 | ₹85.43 - ₹104.41 | -66.1% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹285.41 | ₹256.87 - ₹313.95 | +2.0% | ROE: 10.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹244.31 | ₹219.88 - ₹268.74 | -12.7% | EPS: ₹11.52, BVPS: ₹230.27 |
| Dividend Yield Method | dividend | ₹83.94 | ₹75.55 - ₹92.33 | -70.0% | DPS: ₹2.00, Target Yield: 4.0% |
MEDIASSIST Intrinsic Value vs Market Price — All Valuation Models
Medi Assist Healthcare fair value range ₹84–₹433 vs current market price ₹279.80 across 10 valuation models. For current market price and key ratios, visit Medi Assist Healthcare screener.
MEDIASSIST Intrinsic Value Analysis — Undervalued or Overvalued?
Medi Assist Healthcare median intrinsic value ₹244.31, current price ₹279.80 — Trading Above Median Value by 12.7%, margin of safety -14.5%.
What is the intrinsic value of MEDIASSIST?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Medi Assist Healthcare (MEDIASSIST) is ₹244.31 (median value). With the current market price of ₹279.80, this represents a -12.7% variance from our estimated fair value.
The valuation range spans from ₹83.94 to ₹433.20, indicating ₹83.94 - ₹433.20.
Is MEDIASSIST undervalued or overvalued?
Based on our multi-method analysis, Medi Assist Healthcare (MEDIASSIST) appears to be trading above median value by approximately 12.7%.
MEDIASSIST Financial Health — Key Ratios vs Industry Benchmarks
Medi Assist Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 10.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
MEDIASSIST Cash Flow Quality — Operating & Free Cash Flow
Medi Assist Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹118 Cr | ₹39 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹138 Cr | ₹29 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹66 Cr | ₹39 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹81 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹64 Cr | ₹23 Cr | Positive Free Cash Flow | 7/10 |